IN2014MN01760A - - Google Patents
Info
- Publication number
- IN2014MN01760A IN2014MN01760A IN1760MUN2014A IN2014MN01760A IN 2014MN01760 A IN2014MN01760 A IN 2014MN01760A IN 1760MUN2014 A IN1760MUN2014 A IN 1760MUN2014A IN 2014MN01760 A IN2014MN01760 A IN 2014MN01760A
- Authority
- IN
- India
- Prior art keywords
- relates
- renal
- suspected
- protein
- compositions
- Prior art date
Links
- 206010061481 Renal injury Diseases 0.000 abstract 2
- 102000018704 Chitinase-3-Like Protein 1 Human genes 0.000 abstract 1
- 108010066813 Chitinase-3-Like Protein 1 Proteins 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 238000004393 prognosis Methods 0.000 abstract 1
- 239000000092 prognostic biomarker Substances 0.000 abstract 1
- 238000011269 treatment regimen Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54306—Solid-phase reaction mechanisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4703—Regulators; Modulating activity
- G01N2333/4706—Regulators; Modulating activity stimulating, promoting or activating activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
- G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261603926P | 2012-02-27 | 2012-02-27 | |
| PCT/US2013/028005 WO2013130594A1 (fr) | 2012-02-27 | 2013-02-27 | Procédés et compositions de diagnostic et de pronostic de lésion rénale et d'insuffisance rénale |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN01760A true IN2014MN01760A (fr) | 2015-07-03 |
Family
ID=49083234
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1760MUN2014 IN2014MN01760A (fr) | 2012-02-27 | 2013-02-27 |
Country Status (8)
| Country | Link |
|---|---|
| US (4) | US20150050674A1 (fr) |
| EP (1) | EP2820419B1 (fr) |
| JP (1) | JP6538353B2 (fr) |
| CN (1) | CN104335045B (fr) |
| AU (1) | AU2013226184A1 (fr) |
| CA (1) | CA2865563A1 (fr) |
| IN (1) | IN2014MN01760A (fr) |
| WO (1) | WO2013130594A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10473671B2 (en) | 2014-12-18 | 2019-11-12 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| CN105837706A (zh) * | 2016-03-23 | 2016-08-10 | 卞毓平 | 一种甲壳素的提取方法及甲壳素制品 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| US5939272A (en) | 1989-01-10 | 1999-08-17 | Biosite Diagnostics Incorporated | Non-competitive threshold ligand-receptor assays |
| US5028535A (en) | 1989-01-10 | 1991-07-02 | Biosite Diagnostics, Inc. | Threshold ligand-receptor assay |
| US5922615A (en) | 1990-03-12 | 1999-07-13 | Biosite Diagnostics Incorporated | Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network |
| CA2072758A1 (fr) | 1990-09-14 | 1992-03-15 | Kenneth Francis Buechler | Anticorps liant aux complexes de recepteurs de ligands et de ligands et leur utilite dans les tests ligand-recepteur |
| US5955377A (en) | 1991-02-11 | 1999-09-21 | Biostar, Inc. | Methods and kits for the amplification of thin film based assays |
| CA2107894C (fr) | 1991-04-10 | 2003-10-14 | Kenneth F. Buechler | Subtances inhibitrices |
| EP0579767B1 (fr) | 1991-04-11 | 2000-08-23 | Biosite Diagnostics Inc. | Nouveaux conjugues et dosages destines a la detection simultanee de ligands multiples |
| US6019944A (en) | 1992-05-21 | 2000-02-01 | Biosite Diagnostics, Inc. | Diagnostic devices and apparatus for the controlled movement of reagents without membranes |
| US6143576A (en) | 1992-05-21 | 2000-11-07 | Biosite Diagnostics, Inc. | Non-porous diagnostic devices for the controlled movement of reagents |
| US5494829A (en) | 1992-07-31 | 1996-02-27 | Biostar, Inc. | Devices and methods for detection of an analyte based upon light interference |
| US5824799A (en) | 1993-09-24 | 1998-10-20 | Biosite Diagnostics Incorporated | Hybrid phthalocyanine derivatives and their uses |
| US6113855A (en) | 1996-11-15 | 2000-09-05 | Biosite Diagnostics, Inc. | Devices comprising multiple capillarity inducing surfaces |
| US5947124A (en) | 1997-03-11 | 1999-09-07 | Biosite Diagnostics Incorporated | Diagnostic for determining the time of a heart attack |
| US6057098A (en) | 1997-04-04 | 2000-05-02 | Biosite Diagnostics, Inc. | Polyvalent display libraries |
| JP2006508014A (ja) * | 2001-07-24 | 2006-03-09 | イエール・ユニバーシテイ | キチナーゼおよびキチナーゼ様分子、ならびに炎症性疾患に関する方法、組成物およびキット |
| PL1856153T3 (pl) * | 2005-02-28 | 2011-06-30 | Bio Y As | Przeciwciała monoklonalne YKL-40 |
| US10716749B2 (en) * | 2005-11-03 | 2020-07-21 | Palo Alto Investors | Methods and compositions for treating a renal disease condition in a subject |
| US20100267041A1 (en) * | 2007-09-14 | 2010-10-21 | Predictive Biosciences, Inc. | Serial analysis of biomarkers for disease diagnosis |
| NZ607703A (en) * | 2008-10-21 | 2014-09-26 | Astute Medical Inc | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| EP2694974B1 (fr) * | 2011-04-04 | 2015-10-21 | Universiteit Gent | Biomarqueurs de lésion rénale aiguë |
| US20130035290A1 (en) * | 2011-05-17 | 2013-02-07 | Yale University | Chitinase-3-Like Protein 1 as a Biomarker of Recovery from Kidney Injury |
-
2013
- 2013-02-27 EP EP13755187.5A patent/EP2820419B1/fr active Active
- 2013-02-27 US US14/381,549 patent/US20150050674A1/en not_active Abandoned
- 2013-02-27 CN CN201380020043.XA patent/CN104335045B/zh active Active
- 2013-02-27 WO PCT/US2013/028005 patent/WO2013130594A1/fr not_active Ceased
- 2013-02-27 JP JP2014558962A patent/JP6538353B2/ja active Active
- 2013-02-27 CA CA2865563A patent/CA2865563A1/fr not_active Abandoned
- 2013-02-27 AU AU2013226184A patent/AU2013226184A1/en not_active Abandoned
- 2013-02-27 IN IN1760MUN2014 patent/IN2014MN01760A/en unknown
-
2017
- 2017-05-15 US US15/595,691 patent/US20170248615A1/en not_active Abandoned
-
2018
- 2018-05-16 US US15/981,768 patent/US20180252731A1/en not_active Abandoned
- 2018-12-21 US US16/230,482 patent/US20190120858A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| HK1203620A1 (en) | 2015-10-30 |
| US20180252731A1 (en) | 2018-09-06 |
| US20190120858A1 (en) | 2019-04-25 |
| US20170248615A1 (en) | 2017-08-31 |
| JP6538353B2 (ja) | 2019-07-03 |
| JP2015513673A (ja) | 2015-05-14 |
| EP2820419B1 (fr) | 2020-12-09 |
| CN104335045B (zh) | 2017-02-22 |
| WO2013130594A1 (fr) | 2013-09-06 |
| US20150050674A1 (en) | 2015-02-19 |
| EP2820419A4 (fr) | 2015-08-05 |
| AU2013226184A1 (en) | 2014-09-18 |
| CA2865563A1 (fr) | 2013-09-06 |
| EP2820419A1 (fr) | 2015-01-07 |
| CN104335045A (zh) | 2015-02-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2011106746A1 (fr) | Procédés et compositions pour diagnostic et pronostic de lésion rénale et d'insuffisance rénale | |
| MX2012001559A (es) | Metodos y composiciones para diagnosticos y pronosticos de lesion renal y falla renal. | |
| EP2767833A3 (fr) | Procédés et compositions pour le diagnostic et le pronostic de lésion rénale et d'insuffisance rénale | |
| EA201590027A1 (ru) | Способы детекции заболеваний или состояний | |
| EP3734280A3 (fr) | Procédés et compositions pour le diagnostic et le pronostic de lésions rénales et d'insuffisance rénale | |
| MX2019015159A (es) | Composiciones, metodos y usos para asistir en el diagnostico, pronostico y tratamiento de la fibrosis pulmonar idiopatica. | |
| CY1117784T1 (el) | Μεθοδοι και συνθεσεις για διαγνωση και προγνωση νεφρικης βλαβης και νεφρικης ανεπαρκειας | |
| HK1199099A1 (en) | Methods and compositions for the treatment and diagnosis of cancer | |
| HK1223361A1 (zh) | 用於预测肠易激综合征诊断的途径特异性测定 | |
| MX388231B (es) | Métodos y composiciones para el diagnóstico y pronóstico de lesión renal e insuficiencia renal. | |
| NZ608316A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| MX358474B (es) | Biomarcadores salivales específicos para detección de riesgo, diagnóstico temprano, pronóstico y vigilancia de las enfermedades de alzheimer y de parkinson. | |
| NZ716643A (en) | Methods for predicting the risk of having a cardiovascular event and for monitoring the treatment of a cardiovascular event | |
| EP2474622A4 (fr) | Méthode de diagnostic et/ou de pronostic d'une lésion rénale aiguë | |
| MX2011008323A (es) | Metodos y composiciones para diagnosis y prognosis de lesion renal y falla renal. | |
| MX2019008260A (es) | Metodos y composiciones para la evaluacion y tratamiento de lesion renal e insuficiencia renal con base en la medicion del ligando 14 de quimiocina de la porcion c-c. | |
| WO2015070001A3 (fr) | Compositions et méthodes pour la détection et/ou le traitement d'une inflammation | |
| NZ738100A (en) | Igfbp3 and uses thereof | |
| TR201902845T4 (tr) | Artritik durumların karakterize edilmesine yönelik bileşimler ve yöntemler. | |
| EP2792752A4 (fr) | Méthode pour le diagnostic et/ou le pronostic d'une lésion rénale aiguë | |
| WO2012006394A3 (fr) | Hmga2 en tant que biomarqueur pour le diagnostic et le pronostic du cancer des ovaires | |
| MX2015011804A (es) | Metodos y composiciones para diagnosticar preeclampsia. | |
| WO2014071218A3 (fr) | Biomarqueurs pour le cancer du sein et leurs procédés d'utilisation | |
| WO2015013455A3 (fr) | Méthodes et compositions pour le traitement et le diagnostic du cancer | |
| EP2571515A4 (fr) | Procédés et tests pour le traitement de sujets présentant une délétion, une mutation ou une expression réduite de shank3 |